TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
101.26
-6.86 (-6.34%)
At close: Apr 28, 2026, 4:00 PM EDT
101.69
+0.43 (0.42%)
After-hours: Apr 28, 2026, 7:54 PM EDT
TransMedics Group Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 148.22, with a low estimate of 118 and a high estimate of 175. The average target predicts an increase of 46.38% from the current stock price of 101.26.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TransMedics Group stock from 9 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 3 | 3 | 3 | 3 | 3 |
| Hold | 3 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $170 → $118 | Buy | Maintains | $170 → $118 | +16.53% | Apr 6, 2026 |
| Stifel | Stifel | Hold Maintains $115 → $130 | Hold | Maintains | $115 → $130 | +28.38% | Mar 9, 2026 |
| JP Morgan | JP Morgan | Hold Maintains $114 → $149 | Hold | Maintains | $114 → $149 | +47.15% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $150 → $175 | Buy | Maintains | $150 → $175 | +72.82% | Feb 25, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $140 → $160 | Buy | Maintains | $140 → $160 | +58.01% | Feb 25, 2026 |
Financial Forecast
Revenue This Year
752.35M
from 605.49M
Increased by 24.25%
Revenue Next Year
893.39M
from 752.35M
Increased by 18.75%
EPS This Year
2.48
from 4.87
Decreased by -49.07%
EPS Next Year
3.70
from 2.48
Increased by 49.09%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 786.1M | 966.0M | ||
| Avg | 752.4M | 893.4M | ||
| Low | 696.6M | 833.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 29.8% | 28.4% | ||
| Avg | 24.3% | 18.7% | ||
| Low | 15.0% | 10.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | 3.03 | 4.40 | ||
| Avg | 2.48 | 3.70 | ||
| Low | 1.71 | 2.45 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| High | -37.7% | 77.2% | ||
| Avg | -49.1% | 49.1% | ||
| Low | -65.0% | -1.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.